Published in Clin Vaccine Immunol on July 11, 2007
Varicella zoster disease of the central nervous system: epidemiological, clinical, and laboratory features 10 years after the introduction of the varicella vaccine. J Infect Dis (2010) 1.36
Genotyping of clinical varicella-zoster virus isolates collected in China. J Clin Microbiol (2009) 1.05
Seroprevalence of varicella zoster virus infection in child and adult population of Catalonia (Spain). Med Microbiol Immunol (2007) 0.84
Varicella-zoster virus susceptibility and primary healthcare consultations in Norway. BMC Infect Dis (2016) 0.77
Estimation of the burden of varicella in Europe before the introduction of universal childhood immunization. BMC Infect Dis (2017) 0.75
Estimating Age-Specific Immunity and Force of Infection of Varicella Zoster Virus in Norway Using Mixture Models. PLoS One (2016) 0.75
Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med (2000) 6.43
The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program. N Engl J Med (1994) 4.41
Varicella-zoster virus. Clin Microbiol Rev (1996) 3.03
Zoster sine herpete, a clinical variant. Ann Neurol (1994) 2.84
Restriction fragment length polymorphism of polymerase chain reaction products from vaccine and wild-type varicella-zoster virus isolates. J Virol (1992) 2.37
The epidemiology of varicella and its complications. J Infect Dis (1995) 2.10
Infections of the central nervous system of suspected viral origin: a collaborative study from Finland. J Neurovirol (2001) 1.96
Etiology of aseptic meningitis and encephalitis in an adult population. Neurology (2006) 1.90
Phylogenetic analysis of varicella-zoster virus: evidence of intercontinental spread of genotypes and recombination. J Virol (2002) 1.87
Global identification of three major genotypes of varicella-zoster virus: longitudinal clustering and strategies for genotyping. J Virol (2004) 1.85
Review of varicella zoster seroepidemiology in India and Southeast Asia. Trop Med Int Health (1998) 1.75
Improved identification and differentiation of varicella-zoster virus (VZV) wild-type strains and an attenuated varicella vaccine strain using a VZV open reading frame 62-based PCR. J Clin Microbiol (2000) 1.63
XbaI, PstI, and BglII restriction enzyme maps of the two orientations of the varicella-zoster virus genome. J Virol (1981) 1.58
The molecular epidemiology of varicella-zoster virus: evidence for geographic segregation. J Infect Dis (2002) 1.58
Varicella-zoster virus myelitis: an expanding spectrum. Neurology (1994) 1.53
Effect of climatic factors and population density on varicella zoster virus epidemiology within a tropical country. Am J Trop Med Hyg (2001) 1.50
Rapid genotyping of varicella-zoster virus vaccine and wild-type strains with fluorophore-labeled hybridization probes. J Clin Microbiol (2000) 1.46
Nucleotide sequences that distinguish Oka vaccine from parental Oka and other varicella-zoster virus isolates. J Infect Dis (2000) 1.40
Varicella: clinical manifestations, epidemiology and health impact in children. Pediatr Infect Dis (1985) 1.39
Genetic variation of varicella-zoster virus: evidence for geographical separation of strains. J Med Virol (2003) 1.35
The Immunization Monitoring Program Active (IMPACT) prospective five year study of Canadian children hospitalized for chickenpox or an associated complication. Pediatr Infect Dis J (2000) 1.27
Polymerase chain reaction and restriction fragment length polymorphism analysis of varicella-zoster virus isolates from the United States and other parts of the world. J Infect Dis (1998) 1.24
Analysis of United Kingdom wild-type strains of varicella-zoster virus: differentiation from the Oka vaccine strain. J Med Virol (1997) 1.21
Detection and genotyping of varicella-zoster virus by TaqMan allelic discrimination real-time PCR. J Clin Microbiol (2004) 1.17
Effect of measles, mumps, rubella vaccination on pattern of encephalitis in children. Lancet (1989) 1.17
Application of long PCR method of identification of variations in nucleotide sequences among varicella-zoster virus isolates. J Clin Microbiol (1996) 1.13
Genetic variation in clinical varicella-zoster virus isolates collected in Ireland between 2002 and 2003. J Med Virol (2004) 1.02
Life-threatening complications of varicella. Am J Dis Child (1981) 0.98
Epidemiology of encephalitis in children: a 20-year survey. Ann Neurol (1991) 0.97
Changes in age related seroprevalence of antibody to varicella zoster virus: impact on vaccine strategy. J Clin Pathol (2002) 0.93
Comparative analysis of the restriction endonuclease profiles of the Dumas and Singapore strains of varicella-zoster virus. J Med Virol (1993) 0.92
Investigation of varicella-zoster virus variation by heteroduplex mobility assay. Arch Virol Suppl (2001) 0.90
Genomic analysis of varicella-zoster virus: primers for individual open reading frames. J Clin Virol (2003) 0.88
Varicella seroprevalence and molecular epidemiology of varicella-zoster virus in Argentina, 2002. J Clin Microbiol (2004) 0.87
Infections of the nervous system caused by varicella-zoster virus: a review. Intervirology (1997) 0.86
Lessons from Finland's successful immunization program. N Engl J Med (1994) 0.77
Antibodies to varicella zoster virus in the cerebrospinal fluid of neonates with seizures. Arch Dis Child Fetal Neonatal Ed (1998) 0.77
Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol (2010) 3.52
Varicella zoster virus ischemic optic neuropathy and subclinical temporal artery involvement. Arch Neurol (2011) 2.82
Seroprevalence and correlates of herpes simplex virus type 2 infection in five sexually transmitted-disease clinics. J Infect Dis (2002) 2.08
VZV ischemic optic neuropathy and subclinical temporal artery infection without rash. Neurology (2012) 1.97
Global identification of three major genotypes of varicella-zoster virus: longitudinal clustering and strategies for genotyping. J Virol (2004) 1.85
Incidence of herpes simplex virus type 2 infection in 5 sexually transmitted disease (STD) clinics and the effect of HIV/STD risk-reduction counseling. J Infect Dis (2004) 1.79
Genetic diversity of the 2009 pandemic influenza A(H1N1) viruses in Finland. PLoS One (2010) 1.74
Asymptomatic reactivation and shed of infectious varicella zoster virus in astronauts. J Med Virol (2008) 1.71
DNA sequence variability in isolates recovered from patients with postvaccination rash or herpes zoster caused by Oka varicella vaccine. J Infect Dis (2007) 1.71
Transmission of a newly characterized strain of varicella-zoster virus from a patient with herpes zoster in a long-term-care facility, West Virginia, 2004. J Infect Dis (2008) 1.70
Review of cytomegalovirus shedding in bodily fluids and relevance to congenital cytomegalovirus infection. Rev Med Virol (2011) 1.57
Monkeypox or varicella? Lessons from a rash outbreak investigation in the Republic of the Congo. Am J Trop Med Hyg (2009) 1.54
A proposal for a common nomenclature for viral clades that form the species varicella-zoster virus: summary of VZV Nomenclature Meeting 2008, Barts and the London School of Medicine and Dentistry, 24-25 July 2008. J Gen Virol (2010) 1.49
Complete-genome phylogenetic approach to varicella-zoster virus evolution: genetic divergence and evidence for recombination. J Virol (2006) 1.49
One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose? Pediatrics (2006) 1.48
Cytomegalovirus seroconversion rates and risk factors: implications for congenital CMV. Rev Med Virol (2010) 1.46
High rate of varicella complications among Mexican-born adults in Alabama. Clin Infect Dis (2004) 1.41
Varicella zoster virus vasculopathy: a treatable form of rapidly progressive multi-infarct dementia after 2 years' duration. J Neurol Sci (2012) 1.39
Recurrent polymorphonuclear pleocytosis with increased red blood cells caused by varicella zoster virus infection of the central nervous system: Case report and review of the literature. J Neurol Sci (2010) 1.38
Varicella zoster disease of the central nervous system: epidemiological, clinical, and laboratory features 10 years after the introduction of the varicella vaccine. J Infect Dis (2010) 1.36
National prevalence estimates for cytomegalovirus IgM and IgG avidity and association between high IgM antibody titer and low IgG avidity. Clin Vaccine Immunol (2011) 1.28
Prevalence of and risk factors for viral infections among human immunodeficiency virus (HIV)-infected and high-risk HIV-uninfected women. J Infect Dis (2003) 1.27
Human monkeypox infection: a family cluster in the midwestern United States. J Infect Dis (2004) 1.26
Toward universal varicella-zoster virus (VZV) genotyping: diversity of VZV strains from France and Spain. J Clin Microbiol (2006) 1.23
Serodiagnosis of primary infections with human parvovirus 4, Finland. Emerg Infect Dis (2011) 1.22
Safety of varicella vaccine after licensure in the United States: experience from reports to the vaccine adverse event reporting system, 1995-2005. J Infect Dis (2008) 1.18
Use and limitations of varicella-zoster virus-specific serological testing to evaluate breakthrough disease in vaccinees and to screen for susceptibility to varicella. J Infect Dis (2008) 1.17
An outbreak of varicella in elementary school children with two-dose varicella vaccine recipients--Arkansas, 2006. Pediatr Infect Dis J (2009) 1.15
Varicella seroprevalence in the U.S.: data from the National Health and Nutrition Examination Survey, 1999-2004. Public Health Rep (2010) 1.14
Distribution of varicella-zoster virus (VZV) wild-type genotypes in northern and southern Europe: evidence for high conservation of circulating genotypes. Virology (2008) 1.13
New mosaic subgenotype of varicella-zoster virus in the USA: VZV detection and genotyping by oligonucleotide-microarray. J Virol Methods (2006) 1.11
Mannose-binding lectin 2 gene polymorphism in recurrent herpes simplex virus 2 infection. Hum Immunol (2009) 1.10
Incidence and clinical characteristics of herpes zoster among children in the varicella vaccine era, 2005-2009. J Infect Dis (2013) 1.10
Breast milk-acquired cytomegalovirus infection and disease in VLBW and premature infants. Pediatrics (2013) 1.10
Performance of the Luminex xTAG Respiratory Viral Panel Fast in a clinical laboratory setting. J Virol Methods (2012) 1.08
Evaluation of laboratory methods for diagnosis of varicella. Clin Infect Dis (2010) 1.07
Bufavirus in feces of patients with gastroenteritis, Finland. Emerg Infect Dis (2014) 1.07
Varicella zoster virus meningitis with hypoglycorrhachia in the absence of rash in an immunocompetent woman. J Neurovirol (2009) 1.07
Secondary transmission of varicella vaccine virus in a chronic care facility for children. J Pediatr (2006) 1.05
Genetic profile of an Oka varicella vaccine virus variant isolated from an infant with zoster. J Clin Microbiol (2004) 1.02
Varicella vaccine in the United States: a decade of prevention and the way forward. J Infect Dis (2008) 1.02
Identification of CD8+ T cell epitopes in the immediate early 62 protein (IE62) of varicella-zoster virus, and evaluation of frequency of CD8+ T cell response to IE62, by use of IE62 peptides after varicella vaccination. J Infect Dis (2003) 1.01
Evaluation of multiplex polymerase chain reaction and microarray-based assay for rapid herpesvirus diagnostics. Diagn Microbiol Infect Dis (2012) 1.01
Herpes zoster caused by vaccine-strain varicella zoster virus in an immunocompetent recipient of zoster vaccine. Clin Infect Dis (2014) 1.00
Laboratory diagnosis and characteristics of breakthrough varicella in children. J Infect Dis (2008) 0.98
Deep sequencing of viral genomes provides insight into the evolution and pathogenesis of varicella zoster virus and its vaccine in humans. Mol Biol Evol (2013) 0.98
Herpes zoster with skin lesions and meningitis caused by 2 different genotypes of the Oka varicella-zoster virus vaccine. J Infect Dis (2008) 0.97
Varicella zoster virus DNA at inoculation sites and in saliva after Zostavax immunization. J Infect Dis (2011) 0.96
Draft genome sequences of Bordetella holmesii strains from blood (F627) and nasopharynx (H558). Genome Announc (2013) 0.94
Clinical characteristics of patients with Epstein Barr virus in cerebrospinal fluid. BMC Infect Dis (2011) 0.94
Hepatitis C virus core, NS3, NS4B and NS5A are the major immunogenic proteins in humoral immunity in chronic HCV infection. Virol J (2009) 0.94
Challenges in confirming a varicella outbreak in the two-dose vaccine era. Vaccine (2012) 0.93
Varicella outbreak epidemiology in an active surveillance site, 1995-2005. J Infect Dis (2008) 0.92
Challenges to implementing second-dose varicella vaccination during an outbreak in the absence of a routine 2-dose vaccination requirement--Maine, 2006. J Infect Dis (2008) 0.90
Viruses detected among sporadic cases of parotitis, United States, 2009-2011. J Infect Dis (2013) 0.89
Novel genetic variation identified at fixed loci in ORF62 of the Oka varicella vaccine and in a case of vaccine-associated herpes zoster. J Clin Microbiol (2012) 0.89
Repeated measures study of weekly and daily cytomegalovirus shedding patterns in saliva and urine of healthy cytomegalovirus-seropositive children. BMC Infect Dis (2014) 0.89
Toxoplasmosis in immunocompromized patients. Scand J Infect Dis (2009) 0.88
Subtly impaired humoral immunity predisposes to frequently recurring genital herpes simplex virus type 2 infection and herpetic neuralgia. J Infect Dis (2006) 0.88
Human enterovirus 71 strains in the background population and in hospital patients in Finland. J Clin Virol (2012) 0.88
Subclinical reactivation of varicella zoster virus in all stages of HIV infection. J Neurol Sci (2011) 0.88
Transmission of atypical varicella-zoster virus infections involving palm and sole manifestations in an area with monkeypox endemicity. Clin Infect Dis (2009) 0.88
Chronic active varicella zoster virus infection. Neurology (2012) 0.88
Molecular studies of the Oka varicella vaccine. Expert Rev Vaccines (2011) 0.87
Validity of reported varicella history as a marker for varicella zoster virus immunity among unvaccinated children, adolescents, and young adults in the post-vaccine licensure era. Pediatrics (2009) 0.87
Varicella seroprevalence and molecular epidemiology of varicella-zoster virus in Argentina, 2002. J Clin Microbiol (2004) 0.87
A cluster of primary varicella cases among healthcare workers with false-positive varicella zoster virus titers. Infect Control Hosp Epidemiol (2003) 0.86
Monitoring of viral load by quantitative plasma PCR during active cytomegalovirus infection of individual liver transplant patients. J Clin Microbiol (2002) 0.86
Vaccine Oka variants and sequence variability in vaccine-related skin lesions. J Infect Dis (2008) 0.86
Predictive value of cerebrospinal fluid matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 concentrations in childhood bacterial meningitis. Pediatr Infect Dis J (2014) 0.85
Cytomegalovirus survival on common environmental surfaces: opportunities for viral transmission. J Infect Dis (2011) 0.85
Epidemiology of hepatitis A in Finland in 1990-2007. J Med Virol (2010) 0.85
A large Finnish echovirus 30 outbreak was preceded by silent circulation of the same genotype. Virus Genes (2010) 0.84
Validation and diagnostic application of NS and HA gene-specific real-time reverse transcription-PCR assays for detection of 2009 pandemic influenza A (H1N1) viruses in clinical specimens. J Clin Microbiol (2011) 0.83
Multiplex-PCR and oligonucleotide microarray for detection of eight different herpesviruses from clinical specimens. J Clin Virol (2006) 0.83
Sole infection by human metapneumovirus among children with radiographically diagnosed community-acquired pneumonia in a tropical region. Influenza Other Respir Viruses (2011) 0.83
Serological microarray for detection of HSV-1, HSV-2, VZV, and CMV antibodies. J Virol Methods (2009) 0.82
Hepatitis E virus in patients with unexplained hepatitis in Finland. J Clin Virol (2009) 0.82
Cytomegalovirus survival and transferability and the effectiveness of common hand-washing agents against cytomegalovirus on live human hands. Appl Environ Microbiol (2013) 0.81
Differential diagnosis of acute central nervous system infections in children using modern microbiological methods. Acta Paediatr (2009) 0.81
Polyomavirus BK and JC infections in well matched Finnish kidney transplant recipients. Transpl Int (2009) 0.81
Generation of a reporter cell line for detection of infectious varicella-zoster virus and its application to antiviral studies. Antimicrob Agents Chemother (2006) 0.81
Insights into pediatric herpes simplex encephalitis from a cohort of 21 children from the California Encephalitis Project, 1998-2011. Pediatr Infect Dis J (2014) 0.81
A novel screening method detects herpesviral DNA in the idiopathic pulmonary fibrosis lung. Ann Med (2011) 0.80
A 2009 varicella outbreak in a Connecticut residential facility for adults with intellectual disability. J Infect Dis (2010) 0.80
Scientific commentary. Vaccine (2004) 0.79
Human parechovirus type 3 and 4 associated with severe infections in young children. Pediatr Infect Dis J (2014) 0.79